Company News • Endpoint Arena

News Updates

Thu, May 28, 2026

1 updates

RNXT

8:30 AM

RenovoRx Announces FDA Orphan Drug Designation Granted: Oxaliplatin for the Treatment of Pancreatic Cancer

renovorx.com

Tue, May 26, 2026

1 updates

RNXT

8:30 AM

RenovoRx Announces Promising Pharmacokinetic Data Using the TAMP™ Platform Presented at the 2026 ASCO Annual Meeting

Presentation / Abstract • Phase 3ASCO abstract release Thu, May 21, 2026, 5:00 PM ETrenovorx.com

Tue, May 19, 2026

1 updates

RNXT

8:30 AM

RenovoRx to Present at the Alliance Global Partners Virtual Annual Healthcare Company Showcase on May 20th

Enrollment • Phase 3Enrollment completion Tue, Jun 30, 2026renovorx.com

Thu, May 14, 2026

1 updates

RNXT

4:05 PM

RenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter

Enrollment • Phase 3Enrollment completion Tue, Jun 30, 2026renovorx.com

Wed, Apr 29, 2026

1 updates

RNXT

8:30 AM

RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET

renovorx.com

Thu, Apr 23, 2026

1 updates

RNXT

8:30 AM

RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting

Presentation / Abstract • Phase 3renovorx.com

Tue, Apr 14, 2026

1 updates

RNXT

8:30 AM

Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting

Presentation / Abstractrenovorx.com

Wed, Apr 8, 2026

1 updates

RNXT

8:30 AM

RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum

renovorx.com

Wed, Apr 1, 2026

1 updates

RNXT

2:20 PM

RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026

renovorx.com

Mon, Mar 30, 2026

1 updates

RNXT

4:05 PM

RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update

renovorx.com

Thu, Mar 26, 2026

1 updates

RNXT

8:30 AM

RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment

Enrollment • Phase 3renovorx.com

Mon, Mar 23, 2026

1 updates

RNXT

8:30 AM

RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement

renovorx.com

Fri, Mar 20, 2026

1 updates

RNXT

8:30 AM

RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET

renovorx.com

Wed, Mar 18, 2026

1 updates

RNXT

8:35 AM

RenovoRx Announces $10 Million at Market Private Placement

renovorx.com